Compare FLOC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLOC | DRTS |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | Israel |
| Employees | 1281 | 121 |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.8M | 978.2M |
| IPO Year | N/A | N/A |
| Metric | FLOC | DRTS |
|---|---|---|
| Price | $19.31 | $12.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $28.50 | $8.67 |
| AVG Volume (30 Days) | ★ 831.2K | 797.6K |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.92 | N/A |
| Revenue Next Year | $8.59 | $699.98 |
| P/E Ratio | $16.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.03 | $2.87 |
| 52 Week High | $28.26 | $14.11 |
| Indicator | FLOC | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 29.21 | 65.90 |
| Support Level | $17.46 | $6.59 |
| Resistance Level | $24.37 | N/A |
| Average True Range (ATR) | 1.03 | 0.79 |
| MACD | -0.26 | 0.31 |
| Stochastic Oscillator | 13.41 | 73.27 |
Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.